All News #Library
Biotech
Incyclix Bio Raises $5M for INX-315 CDK4/6 Trial
08 Apr 2026 //
GLOBENEWSWIRE
Incyclix Bio Appoints Dr. Kimberly Blackwell To Board
17 Dec 2025 //
GLOBENEWSWIRE
Incyclix Bio Boost Funding by $11.25M for INX-315 Phase 1/2 Trial
25 Aug 2025 //
GLOBENEWSWIRE
Incyclix Bio Granted FDA Fast Track for INX-315 in Ovarian Cancer
29 Apr 2025 //
GLOBENEWSWIRE
Incyclix Shares INX-315 Phase 1/2 Data For Resistant Cancers
13 Dec 2024 //
GLOBENEWSWIRE
Incyclix Bio Announces Trial Collaboration with Lilly for INX-315
18 Nov 2024 //
GLOBENEWSWIRE
Incyclix Bio Names Dr. Andrew Beelen As VP Of Clinical Development
20 Aug 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support